Mitral regurgitation is the abnormal backward flow of blood from the left ventricle (LV) to the left atrium (LA) due to disease of the mitral valve apparatus (primary MR) or due to dilation of the ...

MR occurs either due to disease involving the mitral valve apparatus, known as primary MR (or “organic” MR), or due to dilation of the mitral valve annulus associated with impaired left ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Out-of-hospital mortality before 30 days was 1.2%, with roughly two-thirds of these patients dying from cardiovascular causes ...

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment management firm ...

C Medical Technologies has closed its Series D financing round, raising gross proceeds of up to $175m. Led by Boston ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical ... System in treating patients with [mitral regurgitation],” 4C Medical CEO Saravana Kumar ...

Find effective medications for 'Mitral Valve Regurgitation and Mitral Valve Replacement treatment right here!' This page is a trusted source for both professionals and patients, detailing brand ...

Dr. C. Michael Gibson talks with Dr. Gregg Stone about the randomized trial of transcatheter mitral valve leaflet approximation in HF patients with secondary MR. COAPT: A Randomized Trial of ...